TAUVID

Eli Lilly and Company🇺🇸 United States

FDA Page

Effective Date: Feb 5, 2024
Approval ID: b483abad-5230-462a-adfb-1a65160f01d0
Products: 0 registered
Version: 8

Regulatory Information

Labeling Type

34391-3

Status

Approved

Full Title

{"br": [null, null, null], "#text": "These highlights do not include all the information needed to use TAUVID safely and effectively. See full prescribing information for TAUVID.\n TAUVID™ (flortaucipir F 18 injection), for intravenous useInitial U.S. Approval: 2020"}

Quick Stats

Total Products0

Labelers1

Label Sections14

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.